
Tatva Chintan Pharma Chem
Tatva Chintan - Chemical Manufacturer, Supplier & Exporter | PTC & QUATS.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Post IPO Equity | |
Total Funding | 000k |










INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 15 % | 45 % | (2 %) | (7 %) | (3 %) | 35 % | 21 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 24 % | 27 % | 16 % | 19 % | 10 % | 19 % | 21 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 18 % | 22 % | 11 % | 8 % | 1 % | 10 % | 11 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Tatva Chintan Pharma Chem Ltd. is an integrated specialty chemical manufacturing company established in 1996. The company was founded by Chintan Shah, Ajay Patel, and Shekhar Somani, all graduates of the Maharaja Sayajirao University of Baroda who embarked on their entrepreneurial journey together. Mr. Shah, the Chairman and Managing Director, holds a degree in Computer Science and manages business development, R&D, exports, and finance. Mr. Patel is a chemical engineer who oversees project engineering and technology implementation, while Mr. Somani, who has a degree in Pharmacy, handles domestic business development, production, and supply chain management.
The company's business model is centered on the manufacturing and distribution of a diverse portfolio of specialty chemicals. Its core product categories include Structure Directing Agents (SDAs), Phase Transfer Catalysts (PTCs), electrolyte salts for supercapacitor batteries, and Pharmaceutical and Agrochemical Intermediates and other Specialty Chemicals (PASC). Tatva Chintan serves a wide range of industries, including automotive, pharmaceuticals, agrochemicals, paints and coatings, and personal care. Revenue is generated through the sale of these specialized chemical products to a global client base, with exports to over 25 countries, including the USA, China, Germany, and Japan. The company holds a significant market position, being one of the largest producers of PTCs in India, the world's second-largest manufacturer of SDAs, and the largest producer of electrolyte salts for supercapacitors in India.
Significant milestones include the incorporation in 1996 with an initial manufacturing capacity of 300 MT in Ankleshwar. The company expanded by starting commercial manufacturing of SDAs in 2011 and establishing a manufacturing facility in Dahej in 2017. A dedicated R&D center was set up in Vadodara in 2018. To support its growing international operations, Tatva Chintan established a North American subsidiary, Tatva Chintan USA Inc., in 2015. A major achievement was its initial public offer (IPO) and subsequent listing on the Indian Stock Exchanges (BSE and NSE) in July 2021. The company emphasizes sustainability, utilizing processes like electrolysis to create products with lower environmental impact.
Keywords: specialty chemicals, structure directing agents, phase transfer catalysts, electrolyte salts, pharmaceutical intermediates, agrochemical intermediates, chemical manufacturing, quaternary ammonium compounds, public company, industrial chemicals, Vadodara, Dahej SEZ, Chintan Shah, Ajay Patel, Shekhar Somani, chemical exports, sustainable chemistry, automotive chemicals, zeolite synthesis, supercapacitor materials